Cancer organoid-based diagnosis reactivity prediction (CODRP) index-based anticancer drug sensitivity test in ALK-rearrangement positive non-small cell lung cancer (NSCLC).
Lee SY, Cho HJ, Choi J, Ku B, Moon SW, Moon MH, Kim KS, Hyun K, Kim TJ, Sung YE, Hwang Y, Lee E, Ahn DH, Choi JY, Lim JU, Park CK, Kim SW, Kim SJ, Koo IS, Jung WS, Lee SH, Yeo CD, Lee DW.
Lee SY, et al. Among authors: moon mh, moon sw.
J Exp Clin Cancer Res. 2023 Nov 22;42(1):309. doi: 10.1186/s13046-023-02899-4.
J Exp Clin Cancer Res. 2023.
PMID: 37993887
Free PMC article.